Developing animals are more sensitive than adults to acute cholinergic toxicity from anticholinesterases, including organophosphorus pesticides, when administered in a laboratory setting. It is also possible that these agents adversely affect the process of neural development itself, leading to permanent deficits in the architecture of the central and peripheral nervous systems. Recent observations indicate that organophosphorus exposure can affect DNA synthesis and cell survival in neonatal rat brain. New evidence that acetylcholinesterase may have a direct role in neuronal differentiation provides additional grounds for interest in the developmental toxicity of anticholinesterases. For example, correlative anatomic studies show that transient bursts of acetylcholinesterase expression often coincide with periods of axonal outgrowth in maturing avian, rodent, and primate brain. Some selective cholinesterase inhibitors effectively suppress neurite outgrowth in model systems like differentiating neuroblastoma cells and explanted sensory ganglia. When enzyme expression is altered by genetic engineering, acetylcholinesterase levels on the outer surface of transfected neurons correlate with ability to extend neurites. Certain of these "morphogenic" effects may depend on protein-protein interactions rather than catalytic acetylcholinesterase activity. Nonetheless, it remains possible that some pesticides interfere with important developmental functions of the cholinesterase enzyme family. -Environ Health Perspect 1 07(Suppl 1):59-64 (1999). http://ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/ 5964brimijoin/abstract.html
Carbamate and organophosphorus pesticides probably owe both their agricultural effectiveness and their primary toxicity to inhibition of acetylcholinesterase (AChE, EC 3.1.1.7). The toxicology of anticholinesterase agents in adults is relatively well understood, but less is known about their effects on the young. When considering the developmental toxicology of anticholinesterase agents, three questions need to be asked: a) Are immature organisms likely to be more sensitive than adults to acute anticholinesterase toxicity, experiencing greater dysfunction at lower levels of exposure? b) Could anticholinesterases cause lasting neurochemical and neurobehavioral deficits in younger organisms? c) Might anticholinesterases even disturb the structure of emerging nervous systems by affecting development itself?
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A short answer to all three questions is that we know too little to draw firm conclusions, and hard data are notably scarce. Nonetheless, there are theoretical grounds for hypothesizing that anticholinesterases might be more dangerous in the young than previously suspected. One reason for concern is new evidence that AChE and the related enzyme, butyrylcholinesterase (BChE, EC 3.1.1.8), also targeted by pesticides, may both have roles in neurologic development. That evidence will be addressed in the next section. First we should review current data on the sensitivity of young animals to toxicity from environmentally relevant anticholinesterase pesticides. Chlorpyrifos, a widely used organophosphate precursor, is an interesting case in point. Neuropathologic studies used to support chlorpyrifos registration with the U.S. Environmental Protection Agency uncovered no evidence of teratogenicity or gross damage to brain structure. However, sophisticated investigations directed at subtler developmental effects have only begun in the past few years.
New results do not disprove the idea that chlorpyrifos is relatively benign, at least in adults, but they raise concerns about its effects on the young. It is now clear that newborn rodents are more sensitive than adults to the acute toxicity of chlorpyrifos in pharmacologic doses (1) (2) (3) . Specifically, rats given chlorpyrifos at postnatal day 17 show behavioral changes, ChE inhibition, and downregulation of muscarinic receptors in the brain at single oral doses of 15 mg/kg, 5-fold lower than required for similar effects in adults (4) . More disturbing are two reports of biochemical and morphologic effects in the newborn rat from chlorpyrifos in very low doses evoking no systemic toxicity. Although AChE activity was not determined, one study showed depressed DNA synthesis throughout the brain when day-old rats received 2 mg/kg chlorpyrifos subcutaneously (5) . Another demonstrated net loss of neurons in the forebrain of 2-week-old rats treated with only 1 mg/kg (6) .
Heightened chlorpyrifos sensitivity in newborns does not reflect postnatal persistence of an intrinsically susceptible, "immature" AChE (7) . Instead the explanation appears to be a relative deficiency of organophosphorus hydrolase enzymes in blood and liver (8) . Issues insufficiently explored are fetal vulnerability and the ability of maternal detoxification and placental barriers to offer meaningful protection in utero. Meanwhile, it is becoming clear that anticholinesterase toxicity may directly or indirectly affect a variety of neural systems. Song et al. (9) found that chlorpyrifos in a subtoxic dose ( (10, 11) , although its physiologic function at such sites is unknown (12) .
The wide cellular distributions of AChE and BChE have fueled speculation that cholinesterases function in ways unrelated to cholinergic neurotransmission-a topic of several current reviews (13, 14) . Proposed noncholinergic roles for AChE range from neuromodulation by secreted forms (15, 16) to promotion of cell proliferation in tumor growth and hematopoiesis (17, 18) . It has also been suggested that AChE facilitates axonal outgrowth and synapse formation, in other words, that it serves as a "morphogenic molecule" in neurons (19) . If this suggestion is valid, then we must consider whether anticholinesterase pesticides might harm immature organisms by hindering the architectural development of their nervous systems. That is admittedly a speculative proposition, especially when it involves judging the risks of low level environmental exposures. The point is, however, that more data are needed on the involvement of AChE in neural development and the potential influence of anticholinesterases on that process.
Cholinesterases and Development of the Nervous System
One reason to suspect a developmental role for AChE is the growth-related shift in molecular forms generated by alternative 3'-mRNA splicing. The developing brain is rich in monomeric and dimeric AChEforms that are mainly intracellular (19) (20) (21) . Adult brain AChE, however, occurs mostly as tetramers anchored to the outer neuronal surface by a hydrophobic peptide. Transition from small intracellular to large extracellular AChE forms occurs during and after synapse formation (20) . The meaning of this shift is unclear, but it might relate to a transition between two roles: first in generating and stabilizing synaptic structures, then in promoting synaptic function. ' The strongest circumstantial evidence for a morphogenic role of AChE lies in the timing of enzyme expression and axonal outgrowth. Neural AChE typically appears while axons are growing and before synaptic connections form (21 (27) . Similarly, during ontogenesis of muscle tissue, motor neurons emerging from the neural tube express AChE as they extend toward the myotome through BChEpositive sclerotomal space (26, 28) . BChE thus precedes AChE in neurons and along the trajectory of their axons, which suggests a coordinated but reciprocal regulation of these two enzymes.
Data also support a developmentally regulated switch from BChE to AChE expression in spinal sensory or dorsal root ganglia (DRG). The DRG form a chain within the vertebral column beside the spinal cord. Each ganglion consists of pseudo-unipolar sensory neuronal cell bodies and satellite (glial) cells. Although the ganglia have no synapses of any kind, all neuronal subpopulations express the full range of cholinergic markers, including choline acetyltransferase (29) (30) (31) . In embryonic chick DRG, total AChE activity per ganglion accumulates steadily with increasing age, but specific AChE activity (units/milligram) rises to a peak at gestational day 12 and then slowly declines to the adult level (32) . In contrast, BChE activity begins high and then drops quickly as the DRG mature (14, 19) . There is a similar pattern of expression in the rat (33) . At embryonic day 9 (E9), before DRG are formed, the neural tube stains heavily for BChE activity ( Figure 1 ). In early DRG as well (El 1-12), quantitative video microscopy shows prominent BChE activity while AChE activity is barely evident. From E13 on, however, AChE activity predominates and reaches high levels in the neuronal cell bodies. At these later stages BChE activity disappears from neurons but becomes highly expressed in glial cells of the surrounding neuropil and ganglionic roots. This distribution of cholinesterases resembles the adult pattern. Not surprisingly, AChE mRNA levels, as determined by polymerase chain reaction (PCR) assay from DRG collected at days E12-E19, vary in parallel with the intensity of enzyme stain. These temporal changes imply that AChE is a postmitotic differentiation mariker that replaces BChE in sensory neurons when cell proliferation is complete.
Molecules Affecting Neurite Outgrowth
When AChE was cloned from Torpedo (34) , mouse (35) , and human sources (36) (49) . Bigbee (52) recently reported even stronger antibody-mediated suppression of neurite extension in cultured rat DRG.
Other investigators have also obtained evidence that AChE promotes neural growth and differentiation by nonenzymatic means. For example, Small (53) reported that substrata containing native and irreversibly inactivated AChE were equally good in stimulating neurite elongation, although heparan sulfate proteoglycans had to be present as well. Similarly, Soreq's group found that increased process extension in glioma cells overexpressing various AChE constructs bore no relation to hydrolytic activity (54) . -::. This growing body of knowledge is exciting to neurobiologists. There are also important toxicologic implications. Although AChE may affect morphogenesis by noncatalytic mechanisms such as structural recognition, these mechanisms could certainly be vulnerable to pesticides. Any anticholinesterase that might alter AChE's steric or electrostatic properties should be suspected as a growth inhibitor until proved innocent. Agents acting at the peripheral site of the enzyme deserve special scrutiny. Most pesticides fall outside this category. However, the toxicologic data reviewed earlier indicate that those agents may have additional actions that would be deleterious to a growing nervous system. It seems wise to re-evaluate the developmental risks of anticholinesterases as data become available from ongoing studies of environmentally relevant molecules in neuronal culture and sensitive embryologic models of neural development.
